S&P Companies not as negative; Gene Therapy manufacturing is stretched thin - a podcast by Life Sciences Rush Hour - Inve

from 2018-11-05T18:28:07

:: ::

Happy national doughnut day! Fewer companies in the S&P are providing negative guidance. What does this mean? How CFOs are protecting their balance sheets in the event their manufacturing is disrupted.